All Releases
Subscribe
Subscribe to Marinomed Biotech AG

29.11.2019 – 07:30

Marinomed Biotech AG

EANS-Tip Announcement: Marinomed Biotech AG
Quarterly report according to art. 126 Stock Exchange Act

--------------------------------------------------------------------------------
  Tip announcement for financial statements transmitted by euro adhoc with the
  aim of a Europe-wide distribution. The issuer is responsible for the content
  of this announcement.
--------------------------------------------------------------------------------

The company Marinomed Biotech AG is declaring the following financial reports
below:

Report Type: Quarterly report according to art. 126 Stock Exchange Act
English:
Publication Date: 29.11.2019
Publication Location: https://www.marinomed.com/en/investors/publications


Further inquiry note:
Dr. Eva Prieschl-Grassauer
Chief Scientific Officer, Marinomed
Veterinärplatz 1, 1210 Vienna, Austria
T +43 (0)1 250 77 4460
E-Mail: eva.prieschl@marinomed.com
http://www.marinomed.com

Roland Mayrl
Managing Partner, Metrum Communications
Bauernmarkt 10/19, 1010 Vienna, Austria
T +43 (0) 1 504 69 87 331
E-Mail: r.mayrl@metrum.at
http://www.metrum.at


end of announcement                         euro adhoc
--------------------------------------------------------------------------------


 
issuer:       Marinomed Biotech AG
              Veterinärplatz 1
              A-1210 Wien
phone:        0043250774460
FAX:          0043250774493
mail:      office@marinomed.com
WWW:       www.marinomed.com
ISIN:         ATMARINOMED6, AT0000A1WD52
indexes:      
stockmarkets: Wien
language:     English
 

Original content of: Marinomed Biotech AG, transmitted by news aktuell